use of ivabradine - a heart rate lowering drug, to reduce heart rate and improve blood pressure in patients with liver disease and sepsis
Phase 2
Completed
- Conditions
- Health Condition 1: K746- Other and unspecified cirrhosis ofliver
- Registration Number
- CTRI/2020/07/026628
- Lead Sponsor
- Amal Francis Sam
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 66
Inclusion Criteria
patients with Child-Pugh A or B cirrhosis with septic shock (as per sepsis 3 guidelines) and Unexplained tachycardia with a heart rate more than 100/min for more 30 minutes
Exclusion Criteria
Acute liver failure
Patients with bradyarrhythmia and tachyarrythmia except sinus tachycardia
Patients on terlipressin therapy
CKD stage 5
Gastric residual volume or aspirate more than 500ml/6hrs
Pregnant patients
Patients who donâ??t give consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method